Vitrolife
Vitrolife AB (publ) completes the acquisition of eFertility
eFertility is an innovative system and software company transforming IVF clinic management with its cutting-edge solutions: eWitness (witnessing system to track and trace each step of the IVF procedure) and eBase (a specialised EMR that is compatible with hospital information systems). eFertility has a leading presence in the Netherlands and is rapidly expanding across Europe. In 2023, the company had revenues of EUR 1.5 million with a strong sales pipeline demonstrating the increased demand for witnessing systems in the IVF market. eFertility will be reported under the Technologies business area.
Gothenburg, May 22, 2024
VITROLIFE AB (publ)
Bronwyn Brophy O’Connor, CEO
The information was submitted for publication, through the agency of the contact persons set out above, at 22-05-2024 13:30 CET.
| Datum | 2024-05-22, kl 13:30 |
| Källa | Cision |
Vill du synas här? Kontakta hej@allaaktier.se. Vår sajt har 100 000 sidvisningar och 15 000 unika besökare per månad. Vår discord har över 6000 medlemmar. Detta är aktiva sparare med ett stort aktieintresse. Behöver du nå ut till denna målgrupp så hör av dig!